Gene-expression signature predicts postoperative recurrence in stage I non-small cell lung cancer patients

Yan Lu, Liang Wang, Pengyuan Liu, Ping Yang, Ming You

Research output: Contribution to journalArticlepeer-review

33 Scopus citations


About 30% stage I non-small cell lung cancer (NSCLC) patients undergoing resection will recur. Robust prognostic markers are required to better manage therapy options. The purpose of this study is to develop and validate a novel gene-expression signature that can predict tumor recurrence of stage I NSCLC patients. Cox proportional hazards regression analysis was performed to identify recurrence-related genes and a partial Cox regression model was used to generate a gene signature of recurrence in the training dataset -142 stage I lung adenocarcinomas without adjunctive therapy from the Director's Challenge Consortium. Four independent validation datasets, including GSE5843, GSE8894, and two other datasets provided by Mayo Clinic and Washington University, were used to assess the prediction accuracy by calculating the correlation between risk score estimated from gene expression and real recurrence-free survival time and AUC of time-dependent ROC analysis. Pathway-based survival analyses were also performed. 104 probesets correlated with recurrence in the training dataset. They are enriched in cell adhesion, apoptosis and regulation of cell proliferation. A 51-gene expression signature was identified to distinguish patients likely to develop tumor recurrence (Dxy = -0.83, P < 1e-16) and this signature was validated in four independent datasets with AUC > 85%. Multiple pathways including leukocyte transendothelial migration and cell adhesion were highly correlated with recurrence-free survival. The gene signature is highly predictive of recurrence in stage I NSCLC patients, which has important prognostic and therapeutic implications for the future management of these patients.

Original languageEnglish (US)
Article numbere30880
JournalPloS one
Issue number1
StatePublished - Jan 23 2012

ASJC Scopus subject areas

  • General


Dive into the research topics of 'Gene-expression signature predicts postoperative recurrence in stage I non-small cell lung cancer patients'. Together they form a unique fingerprint.

Cite this